Defining “platinum-ineligible” patients with metastatic urothelial cancer (mUC).
Year: 2019
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Shilpa Gupta, Guru Sonpavde, Petros Grivas, Andrea B. Apolo, Elizabeth R. Plimack, Thomas W. Flaig, Noah M. Hahn, Arjun Vasant Balar, Dean F. Bajorin, Matt D. Galsky, Jonathan E. Rosenberg, Platinum-Ineligibility in Bladder Cancer Working Group
Institutions: Masonic Cancer Center, Dana-Farber Cancer Institute, University of Washington, National Institutes of Health, National Cancer Institute, Center for Cancer Research, Fox Chase Cancer Center, University of Colorado Cancer Center, Johns Hopkins University, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, Memorial Sloan Kettering Cancer Center, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2922003870